These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21427950)

  • 1. [Effect of Zanamivir substance on infection induced by highly pathogenic avian influenza A/H5N1 in cell cultures].
    Deriabin PG; Galegov GA; Botikov AG; Burtseva EI; Mishin DV; Shchelkanov MIu
    Vopr Virusol; 2011; 56(1):21-4. PubMed ID: 21427950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
    Hurt AC; Selleck P; Komadina N; Shaw R; Brown L; Barr IG
    Antiviral Res; 2007 Mar; 73(3):228-31. PubMed ID: 17112602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells.
    Sithisarn P; Michaelis M; Schubert-Zsilavecz M; Cinatl J
    Antiviral Res; 2013 Jan; 97(1):41-8. PubMed ID: 23098745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.
    Russell RJ; Haire LF; Stevens DJ; Collins PJ; Lin YP; Blackburn GM; Hay AJ; Gamblin SJ; Skehel JJ
    Nature; 2006 Sep; 443(7107):45-9. PubMed ID: 16915235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J; Lee DC; Law AH; Yang CL; Poon LL; Lau AS; Jones SJ
    J Med Chem; 2009 May; 52(9):2667-72. PubMed ID: 19419201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.
    Ye D; Shin WJ; Li N; Tang W; Feng E; Li J; He PL; Zuo JP; Kim H; Nam KY; Zhu W; Seong BL; No KT; Jiang H; Liu H
    Eur J Med Chem; 2012 Aug; 54():764-70. PubMed ID: 22795831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].
    Fediakina IT; Shchelkanov MIu; Deriabin PG; Leneva IA; Gudova NV; Kondrat'eva TV; L'vov DK
    Antibiot Khimioter; 2011; 56(3-4):3-9. PubMed ID: 21913403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology, clinical picture, prevention and treatment of Avian influenza].
    Angelava NA; Angelava AV
    Georgian Med News; 2006 Feb; (131):69-76. PubMed ID: 16575138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.
    Lee SM; Gai WW; Cheung TK; Peiris JS
    Antiviral Res; 2011 Sep; 91(3):330-4. PubMed ID: 21798291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1.
    Udommaneethanakit T; Rungrotmongkol T; Frecer V; Seneci P; Miertus S; Bren U
    Curr Pharm Des; 2014; 20(21):3478-87. PubMed ID: 24001233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Hurt AC; Lowther S; Middleton D; Barr IG
    Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Gubareva LV; Penn CR; Webster RG
    Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice.
    Gubareva LV; McCullers JA; Bethell RC; Webster RG
    J Infect Dis; 1998 Dec; 178(6):1592-6. PubMed ID: 9815209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid derivatives of adamantane carbocycle are capable of inhibiting replication of highly virulent avian influenza A/H5N1 virus.
    Deryabin PG; Garaev TM; Finogenova MP; Botikov AG; Shibnev VA
    Bull Exp Biol Med; 2014 May; 157(1):62-5. PubMed ID: 24909717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS; Wang SQ; Chou KC
    Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the antiviral activity of 2HCl*H-His-Rim compound compared to the anti-influenza drug Arbidol for influenza caused by A/duck/Novosibirsk/56/05 (H5N1) (Influenza A virus, Alphainfluenzavirus, Orthomyxoviridae).].
    Deryabin PG; Garaev TM; Finogenova MP; Odnovorov AI
    Vopr Virusol; 2019; 64(6):268-273. PubMed ID: 32168440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.